{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T05:54:23Z","timestamp":1723182863424},"reference-count":83,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,3,15]]},"DOI":"10.18632\/aging.203924","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T18:12:58Z","timestamp":1646158378000},"page":"2081-2100","source":"Crossref","is-referenced-by-count":4,"title":["Modulation of RNA splicing associated with Wnt signaling pathway using FD-895 and pladienolide B"],"prefix":"10.18632","volume":"14","author":[{"given":"Deepak","family":"Kumar","sequence":"first","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"ThermoFisher Scientific, Carlsbad, CA 92008, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj K.","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"Amity Stem Cell Institute, Amity Medical School, Amity University Haryana, Panchgaon (Manesar), Haryana 122413, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Yu","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ide","family":"Spaanderman","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reymundo","family":"Villa","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"CLL Research Consortium and Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"La Clair","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Burkart","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Januario E.","family":"Castro","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"CLL Research Consortium and Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA"},{"name":"Hematology-Oncology Division, Mayo Clinic, Phoenix, AZ 85054, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/cancers10110458","article-title":"Aberrant RNA Splicing in Cancer and Drug Resistance.","volume":"1","author":"Lee","year":"2018","journal-title":"Cancers (Basel)"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.2174\/1574888X16666211207103628","article-title":"Role of RNA Splicing in Regulation of Cancer Stem Cell.","author":"Kashyap","year":"2021","journal-title":"Curr Stem Cell Res Ther"},{"key":"3","doi-asserted-by":"publisher","first-page":"12052","DOI":"10.1002\/anie.201701065","article-title":"A Challenging Pie to Splice: Drugging the Spliceosome.","volume":"5","author":"Burkart","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15698\/cst2018.03.126","article-title":"The emerging role of minor intron splicing in neurological disorders.","volume":"2","author":"Ruepp","year":"2018","journal-title":"Cell Stress"},{"key":"5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.sbi.2014.01.009","article-title":"The spliceosome: disorder and dynamics defined.","volume":"2","author":"Moore","year":"2014","journal-title":"Curr Opin Struct Biol"},{"key":"6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs.","volume":"1","author":"Valc\u00e1rcel","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"7","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.","volume":"36","author":"Fernandes","year":"2011","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.","volume":"4","author":"Bowcock","year":"2013","journal-title":"Nat Genet"},{"key":"9","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes.","volume":"12","author":"Forbes","year":"2013","journal-title":"Blood"},{"key":"10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1101\/gad.311043.117","article-title":"The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.","volume":"3","author":"Reynolds","year":"2018","journal-title":"Genes Dev"},{"key":"11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.molcel.2018.03.011","article-title":"Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.","volume":"7","author":"Pena","year":"2018","journal-title":"Mol Cell"},{"key":"12","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1038\/s41375-021-01273-7","article-title":"SF3B1 as therapeutic target in FLT3\/ITD positive acute myeloid leukemia.","volume":"3","author":"Kaspers","year":"2021","journal-title":"Leukemia"},{"key":"13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-020-03055-y","article-title":"Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation.","volume":"1","author":"Kommagani","year":"2020","journal-title":"Cell Death Dis"},{"key":"14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","article-title":"Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma.","volume":"49","author":"Nogueiras","year":"2021","journal-title":"Cancer Lett"},{"key":"15","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.7164\/antibiotics.49.1204","article-title":"New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action.","volume":"4","author":"Shimomura","year":"1996","journal-title":"J Antibiot (Tokyo)"},{"key":"16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nchembio.2007.18","article-title":"Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.","volume":"3","author":"Yoshida","year":"2007","journal-title":"Nat Chem Biol"},{"key":"17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/leu.2015.286","article-title":"The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.","volume":"3","author":"Cragg","year":"2016","journal-title":"Leukemia"},{"key":"18","doi-asserted-by":"publisher","first-page":"e0178452","DOI":"10.1371\/journal.pone.0178452","article-title":"Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate.","volume":"1","author":"Graziani","year":"2017","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1038\/srep06098","article-title":"Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells.","volume":"4","author":"Koide","year":"2014","journal-title":"Sci Rep"},{"key":"20","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1158\/1535-7163.MCT-06-0321","article-title":"Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase\/Akt-dependent matrix metalloproteinase-9 expression.","volume":"5","author":"Chung","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1021\/acschembio.6b00562","article-title":"Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant with Improved Activity and Versatile Chemistry.","volume":"1","author":"\u00c1lvarez","year":"2017","journal-title":"ACS Chem Biol"},{"key":"22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1021\/cb100356k","article-title":"Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.","volume":"6","author":"Potter","year":"2011","journal-title":"ACS Chem Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1021\/cb100248e","article-title":"Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product.","volume":"6","author":"Mizukami","year":"2011","journal-title":"ACS Chem Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1101\/gad.2014311","article-title":"Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.","volume":"2","author":"Valc\u00e1rcel","year":"2011","journal-title":"Genes Dev"},{"key":"25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1261\/rna.065383.117","article-title":"Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.","volume":"2","author":"Potter","year":"2018","journal-title":"RNA"},{"key":"26","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41467-017-02007-z","article-title":"Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.","volume":"8","author":"Valc\u00e1rcel","year":"2017","journal-title":"Nat Commun"},{"key":"27","doi-asserted-by":"publisher","first-page":"1177271917730557","DOI":"10.1177\/1177271917730557","article-title":"Changes in Alternative Splicing as Pharmacodynamic Markers for Sudemycin D6.","volume":"1","author":"Stamm","year":"2017","journal-title":"Biomark Insights"},{"key":"28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors.","volume":"3","author":"LoRusso","year":"2014","journal-title":"Invest New Drugs"},{"key":"29","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors.","volume":"1","author":"Tabernero","year":"2013","journal-title":"Clin Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3324\/haematol.2014.122069","article-title":"Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.","volume":"10","author":"Castro","year":"2015","journal-title":"Haematologica"},{"key":"31","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1021\/acschembio.6b00399","article-title":"Selectivity in Small Molecule Splicing Modulation.","volume":"1","author":"Castro","year":"2016","journal-title":"ACS Chem Biol"},{"key":"32","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1021\/jm400861t","article-title":"Stabilized cyclopropane analogs of the splicing inhibitor FD-895.","volume":"5","author":"Burkart","year":"2013","journal-title":"J Med Chem"},{"key":"33","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.18632\/oncotarget.6465","article-title":"Ulocuplumab (BMS-936564 \/ MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.","volume":"7","author":"Kipps","year":"2016","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"publisher","first-page":"13253","DOI":"10.1073\/pnas.1110431108","article-title":"Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.","volume":"10","author":"Carson","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"2","author":"Schmittgen","year":"2001","journal-title":"Methods"},{"key":"36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.","volume":"7","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"37","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function.","volume":"3","author":"Montojo","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/cancers11010119","article-title":"Platinum Resistance in Ovarian Cancer: Role of DNA Repair.","volume":"1","author":"Broggini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13104-020-04996-5","article-title":"MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.","volume":"1","author":"Kirubakaran","year":"2020","journal-title":"BMC Res Notes"},{"key":"40","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jcb.29370","article-title":"PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.","volume":"12","author":"Liu","year":"2020","journal-title":"J Cell Biochem"},{"key":"41","first-page":"993","article-title":"Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.","volume":"1","author":"Mimata","year":"2005","journal-title":"Oncol Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future.","volume":"5","author":"Kroemer","year":"2014","journal-title":"Cell Death Dis"},{"key":"43","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12885-019-5664-7","article-title":"Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC\/ETS-1 signaling pathway.","volume":"1","author":"Dan","year":"2019","journal-title":"BMC Cancer"},{"key":"44","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/nprot.2016.114","article-title":"T-REX on-demand redox targeting in live cells.","volume":"1","author":"Aye","year":"2016","journal-title":"Nat Protoc"},{"key":"45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-015-0266-0","article-title":"Alternative splicing within the Wnt signaling pathway: role in cancer development.","volume":"3","author":"Das","year":"2016","journal-title":"Cell Oncol (Dordr)"},{"key":"46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.yexcr.2015.05.001","article-title":"Expression of WNT genes in cervical cancer-derived cells: Implication of WNT7A in cell proliferation and migration.","volume":"33","author":"Aguilar-Lemarroy","year":"2015","journal-title":"Exp Cell Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.tibs.2009.10.002","article-title":"GSK3: a multifaceted kinase in Wnt signaling.","volume":"3","author":"Pan","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"48","doi-asserted-by":"publisher","first-page":"e1001430","DOI":"10.1371\/journal.pbio.1001430","article-title":"The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas.","volume":"1","author":"Staal","year":"2012","journal-title":"PLoS Biol"},{"key":"49","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.22916","article-title":"Heterogeneous expression of Wnt\/beta-catenin target genes within colorectal cancer.","volume":"12","author":"Kirchner","year":"2007","journal-title":"Int J Cancer"},{"key":"50","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1073\/pnas.0308648100","article-title":"Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.","volume":"10","author":"Carson","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/21691401.2019.1596922","article-title":"Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells.","volume":"4","author":"Zhang","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biopen.2016.02.001","article-title":"CRISPR\/Cas9-mediated target validation of the splicing inhibitor Pladienolide B.","volume":"3","author":"Mahfouz","year":"2016","journal-title":"Biochim Open"},{"key":"53","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1038\/onc.2013.533","article-title":"Hallmarks of alternative splicing in cancer.","volume":"3","author":"Bates","year":"2014","journal-title":"Oncogene"},{"key":"54","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/srep01689","article-title":"RNA sequencing of cancer reveals novel splicing alterations.","volume":"3","author":"Kumar","year":"2013","journal-title":"Sci Rep"},{"key":"55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/onc.2012.38","article-title":"p53 is activated in response to disruption of the pre-mRNA splicing machinery.","volume":"3","author":"Saville","year":"2013","journal-title":"Oncogene"},{"key":"56","first-page":"1653","article-title":"Splicing mutations of the p53 gene in human hepatocellular carcinoma.","volume":"5","author":"Chen","year":"1993","journal-title":"Cancer Res"},{"key":"57","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects.","volume":"3","author":"B\u00fcsselberg","year":"2011","journal-title":"Cancers (Basel)"},{"key":"58","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/ASN.2006020162","article-title":"Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2.","volume":"1","author":"Megyesi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"59","doi-asserted-by":"publisher","first-page":"33147","DOI":"10.1074\/jbc.M805556200","article-title":"The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing.","volume":"28","author":"Moore","year":"2008","journal-title":"J Biol Chem"},{"key":"60","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1021\/jm901215m","article-title":"Synthetic mRNA splicing modulator compounds with in vivo antitumor activity.","volume":"5","author":"Webb","year":"2009","journal-title":"J Med Chem"},{"key":"61","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1093\/nar\/20.17.4613","article-title":"Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues.","volume":"2","author":"Bell","year":"1992","journal-title":"Nucleic Acids Res"},{"key":"62","doi-asserted-by":"publisher","first-page":"14806","DOI":"10.1038\/s41598-018-33094-7","article-title":"Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.","volume":"8","author":"Cho","year":"2018","journal-title":"Sci Rep"},{"key":"63","doi-asserted-by":"publisher","first-page":"35227","DOI":"10.1074\/jbc.M111.233502","article-title":"Activating transcription factor-6 (ATF6) mediates apoptosis with reduction of myeloid cell leukemia sequence 1 (Mcl-1) protein via induction of WW domain binding protein 1.","volume":"28","author":"Nakano","year":"2011","journal-title":"J Biol Chem"},{"key":"64","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ng1760","article-title":"The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.","volume":"3","author":"Lee","year":"2006","journal-title":"Nat Genet"},{"key":"65","doi-asserted-by":"publisher","first-page":"5384","DOI":"10.1093\/nar\/gkq307","article-title":"Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.","volume":"3","author":"Marschalek","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"66","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1242\/dev.02787","article-title":"How is pluripotency determined and maintained?","volume":"13","author":"Niwa","year":"2007","journal-title":"Development"},{"key":"67","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s40778-016-0068-y","article-title":"Wnt Signaling in Normal and Malignant Stem Cells.","volume":"2","author":"Klein","year":"2016","journal-title":"Curr Stem Cell Rep"},{"key":"68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.phymed.2018.06.028","article-title":"HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2-bromo-5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt\/\u03b2-catenin signaling pathway.","volume":"5","author":"Zhang","year":"2018","journal-title":"Phytomedicine"},{"key":"69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases.","volume":"1","author":"He","year":"2009","journal-title":"Dev Cell"},{"key":"70","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1038\/leu.2017.132","article-title":"Wnt5a induces ROR1 to associate with 14-3-3\u03b6 for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.","volume":"3","author":"Kipps","year":"2017","journal-title":"Leukemia"},{"key":"71","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/0092-8674(89)90020-2","article-title":"Distribution of the wingless gene product in Drosophila embryos: a protein involved in cell-cell communication.","volume":"5","author":"Lawrence","year":"1989","journal-title":"Cell"},{"key":"72","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","article-title":"Functional interaction of beta-catenin with the transcription factor LEF-1.","volume":"38","author":"Birchmeier","year":"1996","journal-title":"Nature"},{"key":"73","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3390\/cancers11121883","article-title":"Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5\/WNT2\/GSS Signaling Axis in Oral Squamous Cell Carcinoma.","volume":"1","author":"Bamodu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"74","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1128\/MCB.05103-11","article-title":"Transmembrane protein 198 promotes LRP6 phosphorylation and Wnt signaling activation.","volume":"3","author":"Wu","year":"2011","journal-title":"Mol Cell Biol"},{"key":"75","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1073\/pnas.0911220107","article-title":"LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy.","volume":"10","author":"Bu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/onc.2009.339","article-title":"Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.","volume":"2","author":"Bu","year":"2010","journal-title":"Oncogene"},{"key":"77","doi-asserted-by":"publisher","first-page":"14112","DOI":"10.1073\/pnas.0806158105","article-title":"Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS.","volume":"10","author":"Varmus","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2016.01.018","article-title":"Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.","volume":"4","author":"Rudd","year":"2016","journal-title":"Immunity"},{"key":"79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5808\/GI.2013.11.4.200","article-title":"Review of biological network data and its applications.","volume":"1","author":"Hwang","year":"2013","journal-title":"Genomics Inform"},{"key":"80","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/1878-0261.12052","article-title":"A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.","volume":"1","author":"van Beusechem","year":"2017","journal-title":"Mol Oncol"},{"key":"81","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1038\/s41375-021-01328-9","article-title":"Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms.","volume":"3","author":"Alfonso-Pi\u00e9rola","year":"2021","journal-title":"Leukemia"},{"key":"82","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.","volume":"2","author":"Klimek","year":"2018","journal-title":"Nat Med"},{"key":"83","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1021\/cb300602j","article-title":"Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells.","volume":"8","author":"Koide","year":"2013","journal-title":"ACS Chem Biol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T02:20:50Z","timestamp":1647829250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3,15]]}},"alternative-id":["203924","35230971"],"URL":"https:\/\/doi.org\/10.18632\/aging.203924","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}